The slip
PARKINSON RECEIPTno. 7650
23 Oct 2026, 15:00 UTCdopamine neurons, braak
predictionSRP54 in dopamine neurons tracks Braak Lewy-body stage
registered626b402980097b51
discovery+0.03 p=0.946 n=9
replication+0.44 p=0.238 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho +0.03, p 0.946)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECT4dcab3c2bafa1133b706c552…
follows d9b216088809…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 7650: SRP54 in dopamine neurons, braak
- power
- full sample +0.27 (p 0.277, n 18), 95% CI -0.22 to +0.65. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.23 (p 0.355, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.28 (p 0.261, n 18). could be the mix.
- skeptic
- leave-one-out range +0.18 to +0.43, sign flips 0; without severely affected donors +0.27 (p 0.277, n 18). fragile.
- cell type
- strongest in astrocytes: -0.64 (p 0.0044, n 18) vs +0.27 in dopamine neurons. proposing astrocytes.
- axis
- no measure beats "tracks Braak Lewy-body stage" for SRP54 in dopamine neurons.
follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up SRP54 · astrocytes · braak: substantia nigra, an independent cohort (Parkinson's or LBD vs controls) -0.45 p 0.110 (needs p < 2.8e-4)